Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philip C. Mack
Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients With Non–Small-Cell Lung Cancer: Implications for Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase I/Ii Trial of Pemetrexed Plus Nab-Paclitaxel in Advanced Solid Tumor Patients With Emphasis on Non-Small Cell Lung Cancer
Investigational New Drugs
Oncology
Pharmacology
Escalating Weekly Doses of Cetuximab and Correlation With Skin Toxicity: A Phase I Study
Investigational New Drugs
Oncology
Pharmacology
Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Effects of AKT Inhibition on HGF-mediated Erlotinib Resistance in Non-Small Cell Lung Cancer Cell Lines
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Kidney Cancer
Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients With Advanced Non-Small Cell Lung Cancer and a Performance Status of 2
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
